Senin, 08 Juni 2026 - 00:13 WIB

Find and Follow Us

Global Markets

IHSG 5,594.77 -4.20%

S&P 500 7,383.74 -2.64%

NASDAQ 25,709.43 -4.18%

Dow Jones 50,866.78 -1.35%

FTSE 100 10,368.10 +0.08%

CAC 40 8,218.24 -0.32%

Nikkei 225 66,588.12 -1.31%

Hang Seng 24,961.95 -1.15%

Shanghai 4,027.74 -0.74%

KOSPI 8,160.59 -5.54%

STI 5,049.96 -0.35%

ASX 200 8,625.10 -0.70%

Sensex 74,243.34 -0.16%

Gold 4,365.30 -2.47%

Silver 69.10 -6.34%

Oil (WTI) 90.54 -2.69%

Brent 93.09 -2.04%

Copper 6.28 -3.48%

Gas Alam 3.23 -3.21%

Bitcoin 62,235.97 +2.25%

Ethereum 1,632.02 +4.03%

USD/IDR 18,035.00 +0.44%

EUR/USD 1.15 -0.71%

Advertisement

Executive Director Dexa Laboratories of Biomolecular Sciences, Dr. Raymond Tjandrawinata

Pertama di Indonesia, Dexa Medica Hadirkan Terapi Antibodi Monoklonal dengan Kandungan Regdanvimab untuk…

Redaksi • 01 Agustus 2021

Latest Updates

- Advertisement -

Executive Director Dexa Laboratories of Biomolecular Sciences, Dr. Raymond Tjandrawinata

07:00 WIB • 01 Agustus 2021

Pertama di Indonesia, Dexa Medica Hadirkan Terapi Antibodi Monoklonal dengan Kandungan Regdanvimab untuk Pasien Covid-19

Dexa Medica menghadirkan terapi pengobatan antibodi monoklonal, RegkironaTM dengan kandungan regdanvimab untuk pasien Covid-19.…